These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 22924636

  • 1. Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma.
    Ferreri AJ, Bruno Ventre M, Donadoni G, Cattaneo C, Fumagalli L, Foppoli M, Mappa S, Govi S, Di Nicola M, Rossi G, Tirelli U, Caligaris-Cappio F, Spina M, Re A.
    Br J Haematol; 2012 Oct; 159(2):252-5. PubMed ID: 22924636
    [No Abstract] [Full Text] [Related]

  • 2. High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.
    Wang EH, Chen YA, Corringham S, Bashey A, Holman P, Ball ED, Carrier E.
    Bone Marrow Transplant; 2004 Oct; 34(7):581-7. PubMed ID: 15273714
    [Abstract] [Full Text] [Related]

  • 3. Successful autologous peripheral blood stem cell harvest and transplant in a patient with cold agglutinins.
    Crowther H, Collins D, Antonenas V, McGurgan M, Kerridge I, Gottlieb D, Bradstock K.
    Bone Marrow Transplant; 2006 Feb; 37(3):329-30. PubMed ID: 16299542
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the "CARMEN" phase II trial.
    Ferreri AJM, Cattaneo C, Lleshi A, Verga L, Allione B, Facchetti F, Ponzoni M, Foppoli M, Ferrari D, Rigacci L, Pecciarini L, Donadoni G, Fumagalli L, Sassone M, Calimeri T, Rossi G, Spina M, Re A.
    Br J Haematol; 2021 Jan; 192(1):119-128. PubMed ID: 33085777
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: a single-centre analysis over a 12-year period.
    Haas PS, Bauchmüller K, Kühnemund A, Finke J, Ihorst G, Engelhardt M.
    Ann Hematol; 2006 Mar; 85(3):191-3. PubMed ID: 16365747
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
    Abrey LE, Moskowitz CH, Mason WP, Crump M, Stewart D, Forsyth P, Paleologos N, Correa DD, Anderson ND, Caron D, Zelenetz A, Nimer SD, DeAngelis LM.
    J Clin Oncol; 2003 Nov 15; 21(22):4151-6. PubMed ID: 14615443
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen.
    Farnault L, Venton G, Pourroy B, Jourde-Chiche N, Ivanov V, Arcani R, Roche P, Mercier C, Colle J, Fanciullino R, Costello RT.
    Bone Marrow Transplant; 2019 Jul 15; 54(7):1173-1175. PubMed ID: 30718799
    [No Abstract] [Full Text] [Related]

  • 12. [Intensive treatment of T-cell-rich B lymphoma].
    Azaceta G, Palomera L, Varo MJ, Soria J.
    Sangre (Barc); 1998 Feb 15; 43(1):94-5. PubMed ID: 9577190
    [No Abstract] [Full Text] [Related]

  • 13. Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma.
    Bishton MJ, Haynes AP.
    Br J Haematol; 2007 Jan 15; 136(1):111-3. PubMed ID: 17116129
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunomagnetic selection of CD34(+) cells carried out in cryopreserved cell concentrates from a paediatric patient affected with non-Hodgkin lymphoma.
    Zinno F, Landi F, Aureli V, Cometa AM, Scerpa MC, Caniglia M, Pinto RM, Rana I, Balduino G, Miele MJ, Isacchi G.
    Transfus Med; 2010 Aug 01; 20(4):283-6. PubMed ID: 20136780
    [No Abstract] [Full Text] [Related]

  • 16. Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.
    Geisler CH, Kolstad A, Laurell A, Jerkeman M, Räty R, Andersen NS, Pedersen LB, Eriksson M, Nordström M, Kimby E, Bentzen H, Kuittinen O, Lauritzsen GF, Nilsson-Ehle H, Ralfkiaer E, Ehinger M, Sundström C, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E, Nordic Lymphoma Group.
    Br J Haematol; 2012 Aug 01; 158(3):355-62. PubMed ID: 22640180
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
    Colombat P, Lemevel A, Bertrand P, Delwail V, Rachieru P, Brion A, Berthou C, Bay JO, Delepine R, Desablens B, Camilleri-Broët S, Linassier C, Lamy T.
    Bone Marrow Transplant; 2006 Sep 01; 38(6):417-20. PubMed ID: 16951691
    [Abstract] [Full Text] [Related]

  • 20. [Bacteremia due to Capnocytophaga spp.: two cases].
    García J, Lizasoain M, Lahuerta JJ, Sanz F.
    Enferm Infecc Microbiol Clin; 2003 Mar 01; 21(3):168-9. PubMed ID: 12586027
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.